- Home
- PBF vs KNSA Comparison
PBF vs KNSA Comparison
Compare PBF & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBF | KNSA |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PBF | KNSA |
|---|---|---|
| Price | $49.69 | $45.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | $33.30 | ★ $55.29 |
| AVG Volume (30 Days) | ★ 4.3M | 605.1K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | 69.78 | ★ 225.00 |
| EPS | N/A | ★ 0.75 |
| Revenue | ★ $24,508,200,000.00 | $677,564,000.00 |
| Revenue This Year | $2.09 | $38.01 |
| Revenue Next Year | $0.52 | $17.42 |
| P/E Ratio | ★ N/A | $61.03 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $13.62 | $18.26 |
| 52 Week High | $51.80 | $49.12 |
Technical Indicators
Market Signals| Indicator | PBF | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 49.34 |
| Support Level | $27.35 | $44.36 |
| Resistance Level | N/A | $48.14 |
| Average True Range (ATR) | 2.41 | 1.52 |
| MACD | 0.30 | -0.14 |
| Stochastic Oscillator | 78.96 | 32.28 |
Price Performance
Historical ComparisonAbout PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines, and storage facilities. The Logistics segment consists solely of PBFX's operations.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.